Position in QURE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$4,036,012
-$3,849,518 QoQ
Shares Held
246,851
-25.1% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Dec 31, 2020CallValue
$50,582
CallShares
1,400
PutValue
$737,052
PutShares
20,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. QURE ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in QURE
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,036,012 | 246,851 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $7,885,530 | 329,525 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,226,795 | 295,131 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,976,830 | 141,810 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,037,030 | 380,852 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,219,669 | 69,064 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,239,820 | 251,485 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,187,082 | 264,974 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,635,175 | 314,457 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,860,862 | 274,869 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,375,513 | 354,026 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,674,028 | 320,596 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,991,635 | 247,847 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,419,310 | 194,941 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,777,418 | 201,355 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $639,219 | 34,293 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,596,060 | 143,667 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,328,104 | 160,468 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $957,578 | 29,915 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $404,249 | 13,125 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,932,847 | 87,054 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $50,582 | 1,400 | Call | Defined | 2021-02-10 | |
| 2020-12-31 | $737,052 | 20,400 | Put | Defined | 2021-02-10 | |
| 2020-12-31 | $1,075,047 | 29,755 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $51,562 | 1,400 | Call | Defined | 2020-11-13 | |
| 2020-09-30 | $1,474,229 | 40,028 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $751,332 | 20,400 | Put | Defined | 2020-11-13 | |
| 2020-06-30 | $1,741,207 | 38,642 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $63,084 | 1,400 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $919,224 | 20,400 | Put | Defined | 2020-08-14 | |
| 2020-03-31 | $3,060,760 | 64,505 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $967,980 | 20,400 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $66,430 | 1,400 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||